Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty

• Status: Completed
• Trial end date: 2009-07-01

Summary

This is a Phase 2 3-arm, open label pilot study of the safety and efficacy of Q8003 in patients who have undergone primary unilateral total knee arthroplasty or total hip arthroplasty.

• Phase: Phase 2

Details

• Lead Sponsor: QRxPharma Inc.
• Treatments: Acetaminophen; Acetaminophen, hydrocodone drug combination; Morphine; Oxycodone